Sol-Gel Technologies Total Long Term Liabilities 2016-2024 | SLGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sol-Gel Technologies total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Sol-Gel Technologies Total Long Term Liabilities 2016-2024 | SLGL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sol-Gel Technologies total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19B
Dr Reddy's Laboratories (RDY)	$12B
BridgeBio Pharma (BBIO)	$4.3B
Bausch Health Cos (BHC)	$3B
Amphastar Pharmaceuticals (AMPH)	$2.1B
Supernus Pharmaceuticals (SUPN)	$2B
Taysha Gene Therapies (TSHA)	$434M
Personalis (PSNL)	$261M
Assembly Biosciences (ASMB)	$98M
Evoke Pharma (EVOK)	$7M
Teligent (TLGT)	$0M